Emerging Therapies and challenges for individuals with Angelman syndrome

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Angelman syndrome is a rare neurodevelopmental disorder.
• Current understanding of Angelman syndrome pathophysiology is evolving.
• Limited therapeutic options have historically been available.

Purpose of the Study:

• To review current understandings in the search for therapies for Angelman syndrome.
• To highlight rapid progression in genetic therapies for this disorder.
• To discuss novel therapeutic opportunities based on recent findings.

Main Methods:

• Literature review of recent scientific papers.
• Analysis of preclinical and clinical trial data.
• Exploration of molecular mechanisms underlying Angelman syndrome.

Main Results:

• Significant progress in genetic therapies for Angelman syndrome is evident.
• Novel therapeutics are emerging from preclinical and clinical investigations.
• Enhanced understanding of UBE3A function offers new treatment avenues.

Conclusions:

• Increased knowledge of Angelman syndrome pathophysiology enables novel therapeutic strategies.
• Emerging therapies hold promise for altering the course of the disorder.
• Community support accelerates progress in Angelman syndrome research.